TREMELIMUMAB Drug Record

  • TREMELIMUMAB chembl:CHEMBL2108658 Antineoplastic

    Alternate Names:

    TREMELIMUMAB (GENETICAL RECOMBINATION)
    CP-675206
    TREMELIMUMAB
    TICILIMUMAB
    CP-675,206
    chembl:CHEMBL2108658
    chemidplus:745013-59-6
    drugbank:11771

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    Drug Class Therapeutic Antibodies
    (2 More Sources)

    Publications:

  • MyCancerGenome: TREMELIMUMAB

    • Version: 20-Jun-2017

    Alternate Names:
    CP675 Development Name
    206 Development Name
    TREMELIMUMAB Generic Name

    Drug Info:
    Drug Class Therapeutic Antibodies

    Publications:

  • TdgClinicalTrial: TREMELIMUMAB

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TALC: TREMELIMUMAB

    • Version: 12-May-2016

    Alternate Names:
    TREMELIMUMAB Primary Drug Name
    TREMELIMUMAB Drug Generic Name
    TICILIMUMAB Drug Synonym

    Drug Info:

    Publications:

  • TTD: Tremelimumab

    • Version: 2020.06.01

    Alternate Names:
    D0J6DQ TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2108658

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL2108658

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: